APPLIED THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT November 5, 2018Investors’ Rights Agreement • April 12th, 2019 • Applied Therapeutics Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 12th, 2019 Company Industry JurisdictionTHIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of the 5th day of November, 2018, by and among Applied Therapeutics, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor,” any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof, and Shoshana Shendelman (the “Founder”).
APPLIED THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT November 5, 2018Investors’ Rights Agreement • January 25th, 2019 • Applied Therapeutics Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 25th, 2019 Company Industry JurisdictionTHIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of the 5th day of November, 2018, by and among Applied Therapeutics, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor,” any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof, and Shoshana Shendelman (the “Founder”).